Many health practitioners still believe that Stevens Johnson Syndrome is a “rare skin disorder” but with the increase in adverse drug reactions (Health Canada reports adverse drug reactions are up 35 percent), this life-threatening disease is not as rare as we have been led to believe.
The Stevens Johnson Syndrome Foundation says it hears of 15 new cases a week and that is likely the tip of the iceberg—not everyone diagnosed with SJS has internet access or is aware of the foundation. As well, drug companies are required to tell the FDA (and other health agencies, such as Health Canada) about any reports of serious adverse reactions they receive, but not every doctor or patient takes the time to report side effects. This means that adverse reactions to certain drugs can go unnoticed for a long time.
And to this day, some doctors don’t know what SJS is, even when it’s staring them in the face. When their patient is covered in the most horrific sores and blisters, they might even prescribe the same medication to treat the disease that caused SJS in the first place!
According to Public Citizen, about 1.5 million hospitalizations a year were caused by adverse drug reactions—that’s more than 4,000 patients per day. It gets worse: 57 percent of these adverse drug reactions were not recognized by the attending physician at the time of admission. Many of these admissions should have been prevented. And many patients develop adverse drug reactions while they are in hospital.
“770,000 additional patients a year—more than 2,000 patients a day—suffer an adverse event caused by drugs once they are admitted,” said the not-for-profit agency. In 2004, the Centers for Disease Control (CDC) reported that more than 40 percent of Americans were taking at least one prescription drug. People develop SJS from commonly prescribed drugs, including antibiotics, anti-convulsants, and non-steroidal inflammatory drugs (NSAIDS), including over-the-counter drugs such as Ibuprofen and Motrin. Age is no barrier: Numerous children’s medications have caused SJS.
But countless medical facilities and doctors don’t recognize SJS in the early stages because they aren’t familiar with the symptoms. Until SJS turns into TEN and usually by that time, it’s too late. It boggles the mind: why aren’t all health practitioners given mandatory training to recognize this life-threatening disease? Don’t they read drug labels or their Blue Book before prescribing drugs? It’s like a toss of the dice. When a drug such as Bextra has been known –since 2002—to cause SJS, perhaps the doctor believes the good outweighs the risk.
Just last August Tibotec Therapeutics reported postmarketing cases of SJS with its Intelence drug and the FDA’s MedWatch said “Intelence therapy should be immediately discontinued when signs and symptoms of severe skin or hypersensitivity reactions develop.” How about adding, “get thee to a burn unit, fast.” And bring along a list of drugs that may have caused the reaction.